The required compounds N-aryl-N'-(3-chloro-2-benzo[b]thenoyl)-thioureas 1a-k were prepared by condensing 3-chloro-2-benzo[b]thenoyl chloride with different arylamines using ammonium thiocyanate, which in turn when treated with chloroacetic acid, yielded 1-aryl-3-(3-chloro-2-benzo[b]thenoyl)thiohydantoins 2a-k, while in the presence of sodium acetate treated with chloroacetic acid, yielded 2-arylimino-3-(3-chloro-2-benzo[b]thenoyl)-4-thiazolidinones 3a-k. All the synthesized compounds were screened for their antitubercular and antimicrobial activities. Some selected compounds were selected for their further antitubercular screening.
INTRODUCTION
Thioureas are verstile synthetic intermediate for the preparation of many heterocyclic entities. In the literature, many research workers have reported an S/N regioselective nucleophilic competition in the synthesis of heterocyclic compounds by intermolecular and intramolecular cyclisation reactions. A change in the reaction conditions might favor S-attack or N-attack to afford different cyclic products from the same reaction precursor. Thioureas have been used as intermediates for a great variety of heterocyclic products, such as thiohydantoin, iminothiazolidinone, thioxopyrimidindione, etc. Therefore, it was planned to investigate a system, which combines these thiourea systems for screening the pharmacological properties of the formed compounds. The synthetic potential and biological activity of nitrogen and sulphur containing heterocycles has been explored to the maximum extent and several heterocyclic analogues of thioureas have been reported in recent years. 1, 2 There is considerable interest in the chemotherapeutic activity of thiohydantoins and iminothiazolidinone nucleus bearing a benzo [b] thiophene moiety. This includes anticancer, 3 antiviral, 4 anticonvulsant, 5 anti-inflammatory, 6 antitubercular, 7 etc. agents. Thioureas have been extensively used to synthesize thiohydantoins and iminothiazolidinone derivatives. 8 In the present study, this strategy was used for the synthesis of these compounds in the hope that they may possess different biological activities.
The starting compound N-aryl-N'- (3-chloro-2-benzo[b] thenoyl)thioureas 1a-k were prepared by condensing 3-chloro-2-benzo[b]thenoyl chloride with different arylamines using ammonium thiocyanate, which in turn when treated with chloroacetic acid, yielded the 1-aryl-3-(3-chloro-2-benzo[b]thenoyl)thiohydantoins 2a-k, while in the presence of sodium acetate treated with chloroacetic acid, the 2-arylimino-3-(3-chloro-2-benzo[b]thenoyl)-4-thiazolidinones 3a-k, were formed (Scheme 1).
The structures of the synthesized compounds were assigned on the basis of elemental analysis, IR, 1 H-NMR and mass spectral data. The compounds were screened for their in vitro antitubercular and antimicrobial activities.
EXPERIMENTAL
Thin layer chromatography was used to access the reactions and purity of the compound synthesized. The melting points were determined in open capillaries and are uncorrected. IR spectra were recorded on a Shimadzu FTIR-8400 instrument as KBr discs and only noteworthy absorption levels (cm -1 ) are listed. 1 H-NMR spectra were recorded on a Bruker AC-300 MHz FT NMR spectrometer using TMS as the internal standard, chemical shift in d ppm. Mass spectra were recorded on a Jeol D-300 spectrometer. All the compounds gave satisfactory elemental analyses.
Preparation of
Ammonium thiocyanate (0.76 g, 0.01 mol) in acetone (25 ml) was added dropwise to a solution of 3-chloro-2-benzo[b]thenoyl chloride (2.31 g, 0.01 mol) in acetone (25 ml). 2,6-Dimethylaniline (1.21 g, 0.01 mol) in acetone (25 ml) was then added to the above reaction mixture in small portions; after completion of addition, the reaction mixture was refluxed for 3 h. The excess acetone was then distilled off, the resulting solid was washed with water and crystallized from etha- Table I . (2,6-dimethylphenyl) thiourea (3.74 g, 0.01 mol) was dissolved in the minimum quantity of pyridine. To this solution, chloroacetic acid (1.88 g, 0.02 mol) and 15 ml of dioxane were added. The resulting reaction mixture was refluxed for 12 h. The contents were cooled, poured into ice-cold water, the solid mass was separated, filtered, washed with water and crystallized from benzene. Yield 55 %, m.p. The other 1-aryl-3-(3-chloro-2-benzo[b]thenoyl)thiohydantoins 2a-d, f-k were prepared in a similar manner. The physical and spectral data are recorded in Tables I and II , respectively.
Synthesis of 3-(3-chloro-2-benzo[b]thenoyl)-1-(2,6-dimethylphenyl)-2-thiohydantoin 2e
A mixture of N-(3-chloro-2-benzo[b]thenoyl)-N'-
Synthesis of 3-(3-chloro-2-benzo[b]thenoyl)-2-[(2,6-dimethylphenyl)imino]-4-thiazolidinone 3e
A The other 2-arylimino-3-(3-chloro-2-benzo[b]thenoyl)-4-thiazolidinones 3a-d, f-k were prepared in a similar manner. The physical and spectral data are recorded in Tables I and II, respectively.
RESULTS AND DISCUSSION

Antitubercular activity
The antitubercular evaluation of the compounds was carried out at the Tuberculosis Antimicrobial Acquisition Co-ordinating Facility (TAACF) U.S.A. Primary screening of the compounds for antitubercular activity was conducted at the minimum inhibition concentration of 6.25 mg/ml against Mycobacterium tuberculosis H 37 Rn in BACTEC 12B medium using an ALAMAR radiometric system. The antimycobacterial activity data were compared with the standard drug rifampin at a 0.25 mg/ml concentration, which showed 98 % inhibition (Table III) . 
